| Osborne D Williams, MD | |
|
1000 Montauk Highway, Good Smaritan Hospital Medical Center, West Islip, NY 11795 | |
| (631) 376-4088 | |
| (631) 376-4539 |
| Full Name | Osborne D Williams |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 34 Years |
| Location | 1000 Montauk Highway, West Islip, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275599961 | NPI | - | NPPES |
| 01805852 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 194538 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Long Island Anesthesiologists, Pllc | 5799677902 | 39 |
News Archive
Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.
With a rapidly ageing population and increasing prevalence of hypertension, there is a growing number of people that need to monitor their blood-pressure at home. Whilst the more established home-use digital blood-pressure monitor markets in Western Europe and North America are reaching saturation, the emerging BRIC markets are becoming more aware of lifestyle-related disease prevention and are investing heavily to improve healthcare provisions, driving growth of the blood-pressure monitors market.
On the eve of the 2010-11 influenza flu season, scientists and engineers have identified the environmental conditions and surfaces that could enable a highly pathogenic (H5N1) bird flu virus to survive for prolonged periods of time at least two weeks and up to two months. Among them: The virus appears to thrive at cooler temperatures and low humidity.
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
› Verified 6 days ago
| Entity Name | Good Samaritan Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518901180 PECOS PAC ID: 5294639951 Enrollment ID: O20031124000491 |
News Archive
Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.
With a rapidly ageing population and increasing prevalence of hypertension, there is a growing number of people that need to monitor their blood-pressure at home. Whilst the more established home-use digital blood-pressure monitor markets in Western Europe and North America are reaching saturation, the emerging BRIC markets are becoming more aware of lifestyle-related disease prevention and are investing heavily to improve healthcare provisions, driving growth of the blood-pressure monitors market.
On the eve of the 2010-11 influenza flu season, scientists and engineers have identified the environmental conditions and surfaces that could enable a highly pathogenic (H5N1) bird flu virus to survive for prolonged periods of time at least two weeks and up to two months. Among them: The virus appears to thrive at cooler temperatures and low humidity.
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
› Verified 6 days ago
| Entity Name | Long Island Anesthesiologists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528161171 PECOS PAC ID: 5799677902 Enrollment ID: O20040324001880 |
News Archive
Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.
With a rapidly ageing population and increasing prevalence of hypertension, there is a growing number of people that need to monitor their blood-pressure at home. Whilst the more established home-use digital blood-pressure monitor markets in Western Europe and North America are reaching saturation, the emerging BRIC markets are becoming more aware of lifestyle-related disease prevention and are investing heavily to improve healthcare provisions, driving growth of the blood-pressure monitors market.
On the eve of the 2010-11 influenza flu season, scientists and engineers have identified the environmental conditions and surfaces that could enable a highly pathogenic (H5N1) bird flu virus to survive for prolonged periods of time at least two weeks and up to two months. Among them: The virus appears to thrive at cooler temperatures and low humidity.
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Osborne D Williams, MD 3 Boyle Rd, Selden, NY 11784-4000 Ph: (631) 736-4064 | Osborne D Williams, MD 1000 Montauk Highway, Good Smaritan Hospital Medical Center, West Islip, NY 11795 Ph: (631) 376-4088 |
News Archive
Depression is the most common psychiatric comorbidity in people with epilepsy. Clinical studies have found that 20% to 30% of people with epilepsy have depression; the incidence may be as high as 50% to 55% in people visiting hospital epilepsy centers.
With a rapidly ageing population and increasing prevalence of hypertension, there is a growing number of people that need to monitor their blood-pressure at home. Whilst the more established home-use digital blood-pressure monitor markets in Western Europe and North America are reaching saturation, the emerging BRIC markets are becoming more aware of lifestyle-related disease prevention and are investing heavily to improve healthcare provisions, driving growth of the blood-pressure monitors market.
On the eve of the 2010-11 influenza flu season, scientists and engineers have identified the environmental conditions and surfaces that could enable a highly pathogenic (H5N1) bird flu virus to survive for prolonged periods of time at least two weeks and up to two months. Among them: The virus appears to thrive at cooler temperatures and low humidity.
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy.
› Verified 6 days ago
Terence James Omalley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, Good Samaritan Hospital Medical Center, West Islip, NY 11795 Phone: 631-376-4088 Fax: 631-376-3289 | |
Dr. Claude Simon Gerstenhaber, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, Good Samaritan Hospital Center, West Islip, NY 11795 Phone: 631-376-4088 | |
Roxana Teodora Sacarin, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, Good Samaritan Hospital, West Islip, NY 11795 Phone: 833-547-7463 | |
Dr. Peter A Boulukos, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 471 Montauk Hwy, West Islip, NY 11795 Phone: 631-849-1050 Fax: 631-849-1052 | |
Eric Fanaee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 380 Montauk Hwy, West Islip, NY 11795 Phone: 631-422-5371 | |
Rodolfo M Domingo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Montauk Hwy, Good Samaritan Hospital Medical Center, West Islip, NY 11795 Phone: 631-376-4088 |